Dr. Guy Witberg Presents FFRangio Outcomes Study at ACC 2022
At ACC 2022, Dr. Guy Witberg from Rabin Medical Center presented the first outcomes study demonstrating the safety of managing patients clinically based on the CathWorks FFRangio® System results.
Dr. Witberg has been involved in clinical studies focusing on FFRangio since 2016, including both validation studies and the latest outcomes study. Dr. Witberg spoke with Cath Lab Digest at ACC to explain the Clinical Outcomes of Angiogram-Based FFR Guided Treatment for CAD and why he has been using FFRangio as his standalone FFR tool, replacing wire-based FFR.
